BGLC Earnings Date 2026
BioNexus Gene Lab Corp Common stock earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$1.47
-1.34% today
Earnings Metrics
Revenue Growth
-2.7%
Market Cap
$0.0B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2024 | - | $0.01B | $0.00B |
| Q4 2023 | - | $0.01B | $0.00B |
Trading Around BGLC Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full BGLC Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is BGLC next earnings date?
BGLC (BioNexus Gene Lab Corp Common stock) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is BGLC earnings per share (EPS)?
BGLC's earnings per share data is available in the historical earnings section above.
How often does BGLC report earnings?
Like most publicly traded US companies, BGLC (BioNexus Gene Lab Corp Common stock) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does BGLC report earnings?
BGLC typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has BGLC performed in recent earnings?
In the most recent quarter (Q4 2024), BGLC reported EPS of $N/A on revenue of $0.01B.
What do analysts expect for BGLC earnings?
Analyst expectations for BGLC earnings can vary. The company has shown negative revenue growth of -2.7%. View the full analyst ratings page for detailed expectations.